Cisplatin-induced bradycardia and the importance of the QT interval

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Cisplatin is a very common chemotherapeutic agent used in the treatment of gynecologic malignancies, including cervical, ovarian, and endometrial cancers. Bradycardia is a rare, though potentially severe, side effect of this medication. Here we present the case of a young woman with ovarian cancer who demonstrated significant short-lived cardiotoxicity associated with cisplatin treatment.

Original languageEnglish (US)
Pages (from-to)157-160
Number of pages4
JournalJournal of Oncology Pharmacy Practice
Issue number2
StatePublished - Apr 15 2014
Externally publishedYes


  • arrhythmia
  • Cisplatin
  • ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)


Dive into the research topics of 'Cisplatin-induced bradycardia and the importance of the QT interval'. Together they form a unique fingerprint.

Cite this